Peter Attia hosts Lane Norton, a nutrition scientist and evidence-based researcher, for what was originally planned as the inaugural episode of a rigorous debate series on seed oils. The debate format was designed like a courtroom with pre-submitted evidence, but when the opposing participant withdrew, Attia steel-manned the anti-seed oil position while Norton defended their safety.

The discussion examines whether seed oils pose unique metabolic harm under isocaloric conditions, moving beyond simple excess calorie arguments. Norton brings extensive research background, having changed his own views on LDL cholesterol based on evidence, despite coming from a lab initially skeptical of the lipid hypothesis.

The conversation covers four main arguments against seed oils: mortality data from large RCTs like the Minnesota Coronary Experiment, LDL oxidation mechanisms, industrial processing concerns, and evolutionary/first principles arguments about the 75-fold increase in linoleic acid consumption over 150 years.

The Minnesota and Sydney Heart Studies: Trans Fat Contamination

The Minnesota Coronary Experiment (9,000 subjects, 7 years) showed no mortality benefit despite significant cholesterol reduction when substituting polyunsaturated fats for saturated fats, but margarine contained 25-40% trans fats.

The Sydney Heart Study (458 high-risk men post-MI) showed 74% increased mortality risk (confidence interval 1.04-2.91) in the safflower oil group, but safflower margarine was heavily contaminated with trans fats.

"When these studies were done, they just didn't know that trans fats had that effect" - Lane, explaining why researchers unknowingly introduced the most significant confounder in early polyunsaturated fat trials.

The Rose Corn Oil Trial showed a 364% mortality increase (hazard ratio 4.64) but with massive confidence intervals (0.58-37.15), making the 26-person study statistically meaningless despite dramatic raw numbers.

Finnish Hospital Study: The Gold Standard Crossover Design

The Finnish Hospital Study used 1,200 patients in a 12-year crossover design (6 years each diet), effectively creating 2,400 person-years of data with each subject as their own control.

Results showed 41% cardiovascular risk reduction when increasing polyunsaturated fats to 14% and reducing saturated fats to 9%, with no trans fat or omega-3 contamination.

"Each person is their own control" - Lane, explaining why crossover designs eliminate baseline characteristic differences that can confound parallel group studies.

Meta-analyses excluding trans fat-contaminated studies show 21-29% cardiovascular risk reduction with polyunsaturated fat substitution, while including contaminated studies shows null effects.

LDL Oxidation: Plasma vs Arterial Wall Mechanisms

"Less than 1% of LDL is oxidized in the plasma because LDL is mostly cleared pretty quickly from the plasma... once it penetrates the endothelium, gets inside the intima, 30 to 80% of those particles" oxidize - Lane.

Polyunsaturated fat-enriched LDL particles are more oxidation-prone per particle, but saturated fat creates more total LDL particles entering arterial walls and greater aggregation due to membrane rigidity.

Sphingomyelinase enzyme acts on saturated fat-enriched LDL in arterial walls to rapidly produce ceramides, causing particle collapse and clumping that accelerates plaque formation.

"Think about the LDL cholesterol in your bloodstream being a bonfire... polyunsaturated fat shrinks the bonfire way down, gives off way less sparks" - Lane's analogy for net cardiovascular risk.

Mendelian Randomization: Lifelong LDL Exposure Evidence

Mendelian randomization studies with hundreds of thousands of subjects show "for every one millimole reduction in LDL, which is about 37 milligrams per deciliter, there was a 50 to 55% risk reduction in cardiovascular disease" - Lane.

The genetic variants create "lifelong randomized control trials" with R-values above 0.9, showing consistent effects regardless of which LDL-lowering genetic mechanism is involved.

Statin trials show only 22% risk reduction per equivalent LDL drop because "your entire circulatory system is exposed to less LDL cholesterol" from birth in genetic variants versus starting treatment at age 40-50.

As discussed in Outlive, Mendelian randomization resolved the cholesterol-cancer concern by showing LDL has no causal relationship with cancer risk, unlike its clear cardiovascular effects.

Industrial Processing: Hexane and Oxidation Reality

Hexane residues in processed seed oils are "well under one part per million" with "non-detectable levels" in most products, requiring consumption of "200 to 700 kilograms" of oil for mild toxicity - Lane.

Industrial processing actually reduces oxidation products by 5-10 fold compared to crude oil, with heating done under vacuum (no oxygen) at temperatures below significant oxidation thresholds.

Restaurant frying creates the real oxidation problem: "when you are frying in a thin layer of oil... huge difference in how quickly oxidized and negative products will start to form" compared to industrial processing.

Trans fat formation during processing is minimal at "about 0.5%" of final product, far below the 25-40% levels that confounded early research studies.

The Naturalistic Fallacy and Modern Context

Linoleic acid consumption increased 75-fold over 150 years, but "you have to be logically symmetrical" - modern animal products are equally unnatural compared to ancestral diets - Lane.

The Hadza tribe, our best ancestral diet model, maintains LDL cholesterol levels of 50-70 mg/dL with "almost non-existent rates of cardiovascular disease," supporting lower LDL targets regardless of fat source.

"The average calorie consumption in the United States is 3,500 calories per day, and the average physical activity is less than 20 minutes per day" - Lane, emphasizing that obesity creates 80-200% mortality increases.

"We're stepping over $100 bills picking up pennies" when focusing on seed oil minutiae while ignoring caloric balance, exercise, and overall diet quality - Lane.